Global Molecular Glue Degrader Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Molecular Glue Degrader Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
In particular, molecular glue degraders are monovalent compounds that orchestrate interactions between a target protein and an E3 ubiquitin ligase, prompting the proteasomal degradation of the former.
Molecular Glue Degrader report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Molecular Glue Degrader market is projected to reach US$ 649.6 million in 2034, increasing from US$ 365 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Demand from Cancer Treatment and Infectious Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Molecular Glue Degrader industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Molecular Glue Degrader key manufacturers include Proxygen GmbH, BeyondSpring, Life Sensors, Evotec SE, Eli Lilly and Company, Bristol-Myers Squibb Company, C4 Therapeutics, Incyte and Monte Rosa Therapeutics, etc. Proxygen GmbH, BeyondSpring, Life Sensors are top 3 players and held % sales share in total in 2022.
Molecular Glue Degrader can be divided into Proteolysis Targeting Chimeras (Protags), Specific and Non-Genetic IAP-Dependent Protein Erasers (Snipers) Target Oriented Protein Degrader Optimizer (TORPEDO), Lysosomal Targeting Chimeras (Lyttas) and Others, etc. Proteolysis Targeting Chimeras (Protags) is the mainstream product in the market, accounting for % sales share globally in 2022.
Molecular Glue Degrader is widely used in various fields, such as Cancer Treatment, Infectious Diseases, Genetic Diseases and Others, etc. Cancer Treatment provides greatest supports to the Molecular Glue Degrader industry development. In 2022, global % sales of Molecular Glue Degrader went into Cancer Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Molecular Glue Degrader market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Proxygen GmbH
BeyondSpring
Life Sensors
Evotec SE
Eli Lilly and Company
Bristol-Myers Squibb Company
C4 Therapeutics
Incyte
Monte Rosa Therapeutics
Segment by Type
Proteolysis Targeting Chimeras (Protags)
Specific and Non-Genetic IAP-Dependent Protein Erasers (Snipers) Target Oriented Protein Degrader Optimizer (TORPEDO)
Lysosomal Targeting Chimeras (Lyttas)
Others
Cancer Treatment
Infectious Diseases
Genetic Diseases
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Molecular Glue Degrader market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Molecular Glue Degrader, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Molecular Glue Degrader industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Molecular Glue Degrader in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Molecular Glue Degrader introduction, etc. Molecular Glue Degrader Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Molecular Glue Degrader market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Molecular Glue Degrader report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Molecular Glue Degrader market is projected to reach US$ 649.6 million in 2034, increasing from US$ 365 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Demand from Cancer Treatment and Infectious Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Molecular Glue Degrader industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Molecular Glue Degrader key manufacturers include Proxygen GmbH, BeyondSpring, Life Sensors, Evotec SE, Eli Lilly and Company, Bristol-Myers Squibb Company, C4 Therapeutics, Incyte and Monte Rosa Therapeutics, etc. Proxygen GmbH, BeyondSpring, Life Sensors are top 3 players and held % sales share in total in 2022.
Molecular Glue Degrader can be divided into Proteolysis Targeting Chimeras (Protags), Specific and Non-Genetic IAP-Dependent Protein Erasers (Snipers) Target Oriented Protein Degrader Optimizer (TORPEDO), Lysosomal Targeting Chimeras (Lyttas) and Others, etc. Proteolysis Targeting Chimeras (Protags) is the mainstream product in the market, accounting for % sales share globally in 2022.
Molecular Glue Degrader is widely used in various fields, such as Cancer Treatment, Infectious Diseases, Genetic Diseases and Others, etc. Cancer Treatment provides greatest supports to the Molecular Glue Degrader industry development. In 2022, global % sales of Molecular Glue Degrader went into Cancer Treatment filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Molecular Glue Degrader market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Proxygen GmbH
BeyondSpring
Life Sensors
Evotec SE
Eli Lilly and Company
Bristol-Myers Squibb Company
C4 Therapeutics
Incyte
Monte Rosa Therapeutics
Segment by Type
Proteolysis Targeting Chimeras (Protags)
Specific and Non-Genetic IAP-Dependent Protein Erasers (Snipers) Target Oriented Protein Degrader Optimizer (TORPEDO)
Lysosomal Targeting Chimeras (Lyttas)
Others
Segment by Application
Cancer Treatment
Infectious Diseases
Genetic Diseases
Others
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Molecular Glue Degrader market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Molecular Glue Degrader, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Molecular Glue Degrader industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Molecular Glue Degrader in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Molecular Glue Degrader introduction, etc. Molecular Glue Degrader Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Molecular Glue Degrader market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices